RBGPF
0.0000
Iran executed at least 975 people last year in a "horrifying escalation" of its use of capital punishment, two human rights groups said on Thursday.
A Sri Lankan passenger train derailed Thursday after smashing into a family of elephants, with no passengers injured but six animals killed in the island's worst such wildlife accident, police said.
Myanmar on Thursday handed over the first batch of hundreds of Chinese scam centre workers who are set to be repatriated through Thailand in the coming days.
Ousted South Korean leader Yoon Suk Yeol's lawyer on Thursday said his bid to impose martial law was aimed at thwarting a "legislative dictatorship" by the opposition-controlled parliament, as the president became the country's first sitting head of state to stand trial in a criminal case.
US airline Delta will offer $30,000 to each passenger on a plane that crashed as it landed at Toronto airport this week, the carrier told AFP on Wednesday.
Ousted South Korean leader Yoon Suk Yeol became the country's first sitting head of state to stand trial in a criminal case as hearings opened Thursday on his bid to impose martial law.
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced that it entered into a definitive Securities Purchase Agreement (the "Agreement") on February 19, 2025, pursuant to which the Company issued to the Buyers a senior secured convertible debenture (the "Debenture"). The Debenture is only convertible in the event of a default or at the Company's discretion. The closing of the transaction is expected to occur on February 20, 2025 (the "Closing Date"). The transaction will result in gross proceeds to the Company of $3.0 million. Proceeds from the transaction will support the Company's general working capital and operating expenses.
US President Donald Trump's decision to designate eight Latin American drug trafficking groups as "terrorist" organizations has raised speculation about possible military action on foreign soil.
A US federal judge peppered a top member of Donald Trump's Justice Department with questions Wednesday during a hearing over the office's extraordinary move to drop corruption charges against New York Mayor Eric Adams.
Ousted South Korean leader Yoon Suk Yeol will become the country's first sitting head of state to stand trial in a criminal case as hearings open Thursday on his bid to impose martial law.
From Mexico's most ruthless drug cartels to Central America's most notorious street gang, these are the eight drug trafficking groups being designated terrorist organizations by US President Donald Trump's administration:
Pope Francis's blood tests show a "slight improvement" as he receives hospital treatment for pneumonia, the Vatican said Wednesday, while Italy's prime minister found the 88-year-old joking "as always".
Syria's tiny Jewish community said they held their first group prayer in decades Wednesday, in a synagogue in Damascus's Old City, expressing joy at the long-awaited return to public worship.
Prosecutors demanded a near five-year jail sentence Wednesday for Bosnian Serb leader Milorad Dodik for defying the envoy who oversees the peace accords that ended the country's bloody 1990s war.
Four British women who have accused notorious influencer Andrew Tate of rape said Wednesday they were "concerned" by reports the US government was petitioning Romania to ease his travel restrictions.
A collaboration between the Serbian anti-doping agency and law enforcement operatives who seized 3,000 kilogrammes of performance-enhancing drugs and broke up an organised crime gang last year is "the future in the fight against doping", WADA's Director of Intelligence and Investigations Gunter Younger has told AFP.
Pope Francis's heart is holding up very well despite his pneumonia, a Vatican source said Wednesday, amid growing concerns over the hospitalised 88-year-old's condition.
A new law introduced after a spate of high-profile knife crimes will make it harder for young people to purchase knives online, the UK government announced Wednesday.
Pope Francis, who has been diagnosed with pneumonia in both lungs, passed a "peaceful night", the Vatican said Wednesday, amid growing concerns over the 88-year-old's condition.
An allegedly intoxicated man vandalized a 500-year-old archaeological artifact known as the 12-Angle Stone in Peru, authorities said Tuesday.
The UN nuclear watchdog chief visited Japan's stricken Fukushima plant on Wednesday, the day after Tokyo approved an energy plan that marks a return to nuclear power to meet growing demand for AI.
Bogus child pornography claims, fabricated support for communism and fake posts showing Elon Musk calling for his removal -- a deluge of disinformation is targeting a top judge in suspended South Korean President Yoon Suk Yeol's impeachment trial.
Rapper A$AP Rocky was found not guilty of two counts of felony assault at the conclusion of a trial in Los Angeles on Tuesday.
Duracell® batteries will be integrated into KIFFIK Biomonitoring Devices, such as health monitors, that detect various biomarkers in the body.
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu
New Investor Presentation on Growth Strategy and Expected Sportstech Acquisition
Ambient AI technology can help reduce clinician burnout and enhance patient care
On-demand video webcast now available here
This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of SBS-IF and microvillus inclusion disease (MVID) in the US, EU, and/or Middle East/North Africa regionsAvailability of first IIT proof-of-concept results potentially in H1 2025Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan-Drug Designation by the FDA and the European Medicines Agency (EMA) for both SBS-IF and MVID
NEW YORK CITY, NY / ACCESS Newswire / February 19, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, and PowerUp Acquisition Corp. (Nasdaq:PWUP), a Nasdaq Global Market® listed special purpose acquisition company, ("PowerUp"), today announced the completion of their previously announced business combination (the "Business Combination"). The Business Combination was approved by PowerUp Acquisition Corp. stockholders on January 31, 2025, and it closed on February 17, 2025. Beginning on February 20, 2025, Aspire Biopharma shares of common stock and warrants will begin to trade on the Nasdaq Global Market and Nasdaq Capital Market (collectively, "Nasdaq"), respectively, under the ticker symbols "ASBP" and "ASBPW," respectively.
Pope Francis, who was admitted to hospital last week, has developed pneumonia in both of his lungs, the Vatican announced on Tuesday, adding that the 88-year-old was in "good spirits".
The former trainer of an Argentine Olympic sailor has been arrested in Buenos Aires over claims by the athlete and others that he sexually abused them in their teens, legal sources said Tuesday.